Stay updated on Safe Doses CX-188 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.

Latest updates to the Safe Doses CX-188 in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the 403 error page remains otherwise unchanged.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows a 403 Forbidden error when attempting to view the study record, blocking access to the study content on ClinicalTrials.gov.SummaryDifference15%

- Check54 days agoChange DetectedThe page's Revision line updated from v3.6.5 to v3.6.6, signaling a deployment update to the study details interface.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new deployment of the page's underlying system. This appears to be a platform-level update rather than a change to the study details.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page revision tag was updated to v3.6.4, replacing v3.6.3, indicating a small platform update to the page.SummaryDifference0.1%

Stay in the know with updates to Safe Doses CX-188 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.